Prospective comparison of recurrence score, uPA/PAI-1, central grade and molecular classification in early breast cancer: Interim results from the WSG-Plan B trial.
T. Degenhardt
No relevant relationships to disclose
O. Gluz
Honoraria - Sanofi
H. H. Kreipe
No relevant relationships to disclose
R. E. Kates
No relevant relationships to disclose
C. Liedtke
Honoraria - Sanofi
Other Remuneration - Sanofi
S. Shak
Employment or Leadership Position - Genomic Health
M. R. Clemens
Honoraria - Amgen; Sanofi
Research Funding - Amgen; Sanofi
D. Augustin
No relevant relationships to disclose
U. Nitz
Honoraria - Amgen; Sanofi
Other Remuneration - Amgen; Sanofi
N. Harbeck
Honoraria - Amgen; Sanofi
Other Remuneration - Amgen; Sanofi